Free Trial

Spectral Medical (TSE:EDT) Sets New 12-Month High - Should You Buy?

Spectral Medical logo with Medical background

Spectral Medical Inc. (TSE:EDT - Get Free Report)'s share price reached a new 52-week high on Tuesday . The stock traded as high as C$0.86 and last traded at C$0.86, with a volume of 129000 shares changing hands. The stock had previously closed at C$0.84.

Spectral Medical Price Performance

The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The company's fifty day moving average is C$0.79 and its two-hundred day moving average is C$0.65. The stock has a market cap of C$236.25 million, a price-to-earnings ratio of -12.00 and a beta of 0.96.

Spectral Medical Company Profile

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

See Also

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines